137.79
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt A?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$138.23
Offen:
$136.27
24-Stunden-Volumen:
272.24K
Relative Volume:
0.16
Marktkapitalisierung:
$39.05B
Einnahmen:
$6.79B
Nettoeinkommen (Verlust:
$1.22B
KGV:
32.31
EPS:
4.2644
Netto-Cashflow:
$1.09B
1W Leistung:
-0.50%
1M Leistung:
+11.87%
6M Leistung:
+31.06%
1J Leistung:
-4.43%
Agilent Technologies Inc Stock (A) Company Profile
Firmenname
Agilent Technologies Inc
Sektor
Branche
Telefon
(408) 345-8886
Adresse
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Vergleichen Sie A mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
A
Agilent Technologies Inc
|
137.75 | 38.73B | 6.79B | 1.22B | 1.09B | 4.2644 |
![]()
TMO
Thermo Fisher Scientific Inc
|
522.96 | 198.09B | 43.21B | 6.58B | 6.17B | 17.28 |
![]()
DHR
Danaher Corp
|
205.19 | 144.97B | 24.01B | 3.41B | 4.86B | 4.7082 |
![]()
IDXX
Idexx Laboratories Inc
|
632.36 | 49.29B | 4.04B | 985.66M | 774.34M | 12.01 |
![]()
IQV
Iqvia Holdings Inc
|
204.19 | 33.69B | 15.70B | 1.24B | 2.01B | 6.9036 |
Agilent Technologies Inc Stock (A) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-10-08 | Eingeleitet | Rothschild & Co Redburn | Buy |
2025-10-08 | Hochstufung | UBS | Neutral → Buy |
2025-02-10 | Hochstufung | Barclays | Underweight → Equal Weight |
2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
2024-07-10 | Hochstufung | Citigroup | Neutral → Buy |
2024-06-27 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
2024-06-03 | Fortgesetzt | Jefferies | Hold |
2024-04-05 | Hochstufung | Stifel | Hold → Buy |
2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
2023-12-12 | Herabstufung | BofA Securities | Buy → Neutral |
2023-11-17 | Herabstufung | UBS | Buy → Neutral |
2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
2023-07-31 | Herabstufung | Evercore ISI | Outperform → In-line |
2023-05-24 | Bestätigt | Barclays | Equal Weight |
2023-05-24 | Bestätigt | BofA Securities | Buy |
2023-05-24 | Bestätigt | Citigroup | Neutral |
2023-05-24 | Bestätigt | Credit Suisse | Outperform |
2023-05-24 | Bestätigt | Evercore ISI | Outperform |
2023-05-24 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
2023-05-24 | Bestätigt | Robert W. Baird | Outperform |
2023-05-24 | Bestätigt | SVB Securities | Outperform |
2023-05-24 | Bestätigt | Stifel | Hold |
2023-05-24 | Bestätigt | TD Cowen | Outperform |
2023-05-24 | Bestätigt | Wells Fargo | Overweight |
2023-05-11 | Eingeleitet | Barclays | Equal Weight |
2023-01-10 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
2022-07-20 | Eingeleitet | UBS | Buy |
2022-07-08 | Herabstufung | Citigroup | Buy → Neutral |
2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
2022-02-23 | Bestätigt | BofA Securities | Buy |
2022-02-23 | Bestätigt | Citigroup | Buy |
2022-02-23 | Bestätigt | Cowen | Outperform |
2022-02-23 | Bestätigt | Evercore ISI | Outperform |
2022-02-23 | Bestätigt | Stifel | Hold |
2022-02-23 | Bestätigt | Wells Fargo | Overweight |
2021-11-23 | Bestätigt | BofA Securities | Buy |
2021-11-23 | Bestätigt | Cowen | Outperform |
2021-11-23 | Bestätigt | Stifel | Hold |
2021-03-18 | Hochstufung | Citigroup | Neutral → Buy |
2021-02-17 | Hochstufung | BofA Securities | Neutral → Buy |
2020-12-02 | Eingeleitet | Goldman | Buy |
2020-11-25 | Hochstufung | UBS | Neutral → Buy |
2020-11-17 | Hochstufung | Cleveland Research | Neutral → Buy |
2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
2020-09-30 | Eingeleitet | Atlantic Equities | Neutral |
2020-08-19 | Bestätigt | BofA Securities | Neutral |
2020-08-19 | Bestätigt | Citigroup | Neutral |
2020-08-19 | Bestätigt | Jefferies | Buy |
2020-08-19 | Bestätigt | Robert W. Baird | Outperform |
2020-08-19 | Bestätigt | SVB Leerink | Outperform |
2020-08-19 | Bestätigt | Stifel | Hold |
2020-08-19 | Bestätigt | Wells Fargo | Overweight |
2020-02-24 | Herabstufung | Needham | Buy → Hold |
2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
2020-01-07 | Eingeleitet | Citigroup | Neutral |
2019-11-26 | Bestätigt | Needham | Buy |
2019-11-15 | Eingeleitet | Stifel | Hold |
2019-10-18 | Herabstufung | UBS | Buy → Neutral |
2019-07-16 | Herabstufung | BofA/Merrill | Buy → Neutral |
2019-07-15 | Herabstufung | Barclays | Overweight → Equal Weight |
Alle ansehen
Agilent Technologies Inc Aktie (A) Neueste Nachrichten
Agilent Technologies (A) Sees Price Target Boost by TD Cowen | A Stock News - GuruFocus
TD Cowen Adjusts Price Target on Agilent Technologies to $162 From $150, Maintains Buy Rating - MarketScreener
What technical models suggest about Agilent Technologies Inc.’s comebackTrade Entry Report & Smart Money Movement Tracker - newser.com
Will Agilent Technologies Inc. stock outperform value stocksTrade Risk Report & Community Verified Swing Trade Signals - newser.com
How currency fluctuations impact Agilent Technologies Inc. stock2025 Key Highlights & High Return Stock Watch Alerts - newser.com
Analyzing recovery setups for Agilent Technologies Inc. investorsNew Guidance & High Accuracy Trade Signal Alerts - newser.com
Predicting Agilent Technologies Inc. trend using moving averages2025 Macro Impact & Weekly Watchlist for Consistent Profits - newser.com
Is Agilent Technologies Inc. stock a contrarian buyNew Guidance & Breakout Confirmation Trade Signals - newser.com
What momentum indicators show for Agilent Technologies Inc. stockInflation Watch & Safe Entry Point Identification - newser.com
How Agilent Technologies Inc. stock benefits from tech adoptionMarket Movers & Daily Volume Surge Trade Alerts - newser.com
Microfluidic Market to See Booming Growth 2025-2032 | Agilent Technologies, Inc., Illumina, Inc. - openPR.com
SPT Labtech and Agilent introduce automated target enrichment protocols for genomic workflows - News-Medical
Agilent Technologies, Inc. (A) Stock Analysis: Potential 8.16% Upside and Robust Revenue Growth - DirectorsTalk Interviews
Agilent Technologies (A): Evaluating Valuation After Analyst Upgrades and New Product Launches Drive Market Optimism - simplywall.st
Callan Family Office LLC Grows Position in Agilent Technologies, Inc. $A - MarketBeat
Is Agilent Technologies Inc. (AG8) stock resilient in recession scenarios2025 Technical Overview & Stock Timing and Entry Methods - newser.com
Does Agilent’s Security Tech Launch Signal a New Growth Avenue for Agilent Technologies (A)? - simplywall.st
NI, Agilent Technologies Ally to Create Drivers | light speed | Oct 2006 - Photonics Spectra
Agilent Technologies Opens Spectroscopy Facility in UK | RapidScan | Jan/Feb 2020 - Photonics Spectra
Agilent Technologies Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Is Agilent Technologies Inc. building a consolidation baseWeekly Stock Report & Momentum Based Trading Ideas - newser.com
What MACD signals say about Agilent Technologies Inc.2025 Retail Activity & High Return Stock Watch Alerts - newser.com
Visual analytics tools that track Agilent Technologies Inc. performancePortfolio Growth Summary & Consistent Return Investment Signals - newser.com
Agilent and Aeroflex Microelectronic Partner for RF Solutions - Photonics Spectra
Newborn Screening Market Huge Growth in Future Scope 2025-2032 | Agilent Technologies, Inc., Bio-rad laboratories, Inc. - industrytoday.co.uk
Is Agilent Technologies Inc. a candidate for recovery playEarnings Risk Report & High Yield Stock Recommendations - newser.com
JP Morgan Maintains Agilent Technologies (A) Overweight Recommendation - Nasdaq
Agilent Technologies (A) Receives Raised Price Target from JP Mo - GuruFocus
JPMorgan Adjusts PT on Agilent Technologies to $165 From $155, Maintains Overweight Rating - MarketScreener
Key resistance and support levels for Agilent Technologies Inc.July 2025 Pullbacks & Daily Stock Trend Watchlist - newser.com
Published on: 2025-10-09 03:50:55 - newser.com
Why Agilent Technologies Inc. stock is a must watch in 20252025 Market WrapUp & Precise Buy Zone Identification - newser.com
Custom strategy builders for tracking Agilent Technologies Inc.Analyst Downgrade & High Yield Stock Recommendations - newser.com
Best data tools to analyze Agilent Technologies Inc. stock2025 AllTime Highs & Accurate Entry/Exit Alerts - newser.com
Risk adjusted return profile for Agilent Technologies Inc. analyzedWeekly Investment Report & Verified Stock Trade Ideas - newser.com
TRADE NEWS: Agilent Technologies and Shimadzu to Exchange Chromatography Instrument Drivers - AOL.com
Agilent Technologies 'Well Positioned' to Accelerate Sales Growth in 2027, UBS Says - MarketScreener
Agilent Technologies (A) Receives Boost After UBS Upgrade - GuruFocus
Agilent upgraded to Buy at UBS on growth outlook - MSN
UBS Upgrades Agilent Technologies to Buy From Neutral, Raises Price Target to $170 From $130 - MarketScreener
UBS Upgrades Agilent Technologies (A) - Nasdaq
SPT Labtech and Agilent Introduce Automated Target Enrichment Protocols for Genomic Workflows - the-scientist.com
UBS upgrades Agilent on China, pharma lab demand; sees 20%+ upside By Investing.com - Investing.com Nigeria
UBS upgrades Agilent on China, pharma lab demand; sees 20%+ upside - Investing.com Canada
Agilent Technologies (A) Receives Upgrade from UBS with Raised P - GuruFocus
This W.W. Grainger Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Wednesday - Benzinga
Agilent Technologies (NYSE:A) Upgraded to Buy at UBS Group - MarketBeat
Rothschild & Co Initiates Coverage of Agilent Technologies (A) with Buy Recommendation - Nasdaq
Agilent Technologies (A) Receives 'Buy' Rating from Rothschild & Co | A Stock News - GuruFocus
Rothschild & Co Redburn Initiates Agilent Technologies at Buy With $165 Price Target - MarketScreener
Rothschild Redburn initiates Agilent stock with Buy rating, $165 target - Investing.com
Finanzdaten der Agilent Technologies Inc-Aktie (A)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):